Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, agilon health, inc. reported revenue of $5.93B, down 2.1% year over year. Operating margin was -7.8% and net margin -6.6%, on a free-cash-flow margin of -2.0% with capital expenditure at 0.2% of revenue. Every figure is computed directly from AGL's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $5.93B | -7.8% | -6.6% |
| FY2024 | $6.06B | -4.8% | -4.3% |
| FY2023 | $4.32B | -5.4% | -6.1% |
| FY2022 | $2.39B | -4.4% | -4.5% |
| FY2021 | $1.52B | -24.5% | -26.7% |
How does AGL compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 23 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: HCA · THC · UHS · LH · DVA · CYH
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.